Zelluna ASA (OSL:ZLNA)

Norway flag Norway · Delayed Price · Currency is NOK
9.37
+0.12 (1.25%)
At close: Dec 5, 2025
Market Cap191.55M
Revenue (ttm)53.00K
Net Income (ttm)-122.19M
Shares Out20.45M
EPS (ttm)-30.91
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16,374
Average Volume20,154
Open9.80
Previous Close9.25
Day's Range8.70 - 9.80
52-Week Range8.20 - 22.50
Betan/a
RSI46.91
Earnings DateNov 6, 2025

About Zelluna ASA

Zelluna ASA develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers. The company was founded in 2016 and is based in Oslo, Norway. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 22
Stock Exchange Oslo Børs
Ticker Symbol ZLNA
Full Company Profile

Financial Performance

Financial Statements

News

Zelluna ASA (OSL:ZLNA) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial Insights

Zelluna ASA (OSL:ZLNA) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial Insights

4 weeks ago - GuruFocus

Q3 2025 Zelluna ASA Earnings Call Transcript

Q3 2025 Zelluna ASA Earnings Call Transcript

4 weeks ago - GuruFocus